Tretinoin cannot be used during pregnancy or while nursing, so it may not be an option

availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial

Legislation PSM monitors new state legislation weekly in the areas of pill presses, prescription drug affordability boards, and drug importation
For researchers interested in exploring related metabolic peptides, compounds like AOD 9604 offer complementary research opportunities in fat metabolism pathways
In this guide, well break down: How injectables, oral, and capsule forms of BPC157 compare Which form delivers the best bioavailability and results How to choose the right format for gut health, muscle recovery, or injury repair For a complete breakdown of how BPC157 works, see our companion article: What Is BPC157